Clinical Trial Site

Porto Alegre, Rio Grande do Sul 91350-200

1 studies enrolling now · 1 studies all time

What they study most

Advanced Breast Cancer, Breast Cancer, ER Positive Breast Cancer, HER2 Negative Breast Carcinoma, Metastatic Breast Cancer

Studies at this site

• OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer — Recruiting now